This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: François Petitet: Innovator in Pharmaceutical Compositions
Introduction
François Petitet is a notable inventor based in Créteil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obesity. With a total of 2 patents to his name, Petitet's work focuses on innovative combinations of pharmaceutical compounds.
Latest Patents
François Petitet's latest patents include a groundbreaking invention that involves the combination of a CB1 receptor antagonist and sibutramine. This invention details the pharmaceutical compositions comprising these compounds and their application in treating obesity. The significance of this work lies in its potential to offer new therapeutic options for individuals struggling with weight management.
Career Highlights
Throughout his career, François Petitet has been associated with Aventis Pharma S.A., where he has contributed to various research initiatives. His expertise in pharmaceutical sciences has allowed him to develop innovative solutions that address pressing health issues.
Collaborations
François Petitet has collaborated with esteemed colleagues such as Odile Piot-Grosjean and Philippe Picaut. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.
Conclusion
François Petitet's contributions to the pharmaceutical industry, particularly in obesity treatment, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile